INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 290 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,947,000 | -49.4% | 52,213 | -65.2% | 0.06% | -70.2% |
| Q3 2020 | $3,849,000 | +372.3% | 150,000 | +37.5% | 0.20% | +42.4% |
| Q3 2019 | $815,000 | -79.1% | 109,130 | -63.6% | 0.14% | -76.5% |
| Q2 2019 | $3,894,000 | +219.7% | 300,000 | +200.0% | 0.59% | +241.6% |
| Q1 2019 | $1,218,000 | +285.4% | 100,000 | +261.0% | 0.17% | +174.6% |
| Q4 2018 | $316,000 | -92.5% | 27,700 | -85.7% | 0.06% | -92.8% |
| Q3 2018 | $4,191,000 | +427.2% | 193,100 | +329.1% | 0.88% | +177.0% |
| Q2 2018 | $795,000 | – | 45,000 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 175,000 | $9,115,750 | 10.70% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 317,856 | $16,547,583 | 5.57% |
| Deep Track Capital, LP | 2,600,000 | $135,434,000 | 5.23% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,369,849 | $71,355,434 | 3.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,730 | $10,872,746 | 3.30% |
| DCF Advisers, LLC | 107,157 | $5,581,808 | 3.04% |
| Bellevue Group AG | 3,170,250 | $165,138,323 | 2.66% |
| Vahanian & Associates Financial Planning Inc. | 15,217 | $792,654 | 2.55% |
| Iron Triangle Partners LP | 330,549 | $17,218,297 | 2.52% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $15,627,000 | 2.20% |